A PHASE 1/2 FIRST-IN-HUMAN STUDY OF BMS-986288 ALONE AND IN COMBINATION WITH NIVOLUMAB IN ADVANCED MALIGNANT TUMORS

Registry ID

CA043-001

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

BRISTOL-MYERS SQUIBB CANADA

Start date

2023-11-14

Last update

2019-05-23

Conditions

• ADVANCED MALIGNANT TUMORS

Related clinical trials

• A PHASE 1B/2 CLINICAL STUDY OF INTRATUMORAL ADMINISTRATION OF V937 IN COMBINATION WITH PEMRBOLIZUMAB (MK-3475) IN PARTICIPANTS WITH ADVANCED/METASTATIC SOLIC TUMORS

View on source registry